Click here to go to the previous page
Innovation and Evolution Within the Medical Science Liaison Role
Program Code:
208
Date:
Tuesday, June 25, 2013
Time:
8:00 AM to 9:30 AM
EST
CHAIR
:
J. Lynn Bass,
PharmD,RPh (SCHNON), Director, Medical Scientists,
Jazz Pharmaceuticals, United States
Lynn has over 12 years of experience as a Sr. Medical Science Liaison with Baxter, Lilly, and Amgen. She has been an active member of the Medical Communications SIAC for over 9 years and has co-authored six MSL surveys. She serves as a leader within the Medical Science Liaison community at DIA.
|
SPEAKER
(S):
Jane W Springer, BSN,RN (SPKNON), Principal Specialist, Medical Relations and Information, Amylin Pharmaceuticals, LLC, A Subsidiary of Bristol-Myers Squibb, United States
Robin Winter-Sperry, MD is the President & CEO of Scientific Advantage, a firm that specializes in Medical Affairs, Medical Science Liaisons and Medical Information Services. Dr. Winter-Sperry is a leading authority on MSLs, an international speaker, author and Medical Affairs strategist.
|
Description
The pharmaceutical industry is composed of diverse constituents who, as a whole, result in a unique, overall industry composite. Since the inaugural team of Medical Science Liaisons (MSL) was deployed, the role and function of the individual MSL has evolved and pivoted in numerous directions. Modern day MSLs continue to evolve and represent the crucial link between the academic and investigator community with the pharmaceutical manufacturer. In this symposium, we will explore how an experienced MSL continues to develop professionally; the evolution, innovation, and challenges of the MSL's use of technology in their roles; and the future role of the MSL in educational activities.